C4 Therapeutics, Inc.: cashflow_financing
| Value | {"amount": -684000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-03-31 |
| Status | current |
| Entity | C4 Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/44325f82-c4f1-4b0d-90f6-501b0cc1c26d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-23-015459Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001662579/cashflow-financing/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/44325f82-c4f1-4b0d-90f6-501b0cc1c26d
History
- no predecessors — first report